IL147154A - Polymorphic salt of eletriptan hemisulphate and its use in the preparation of a medicament for the treatment of migraine - Google Patents

Polymorphic salt of eletriptan hemisulphate and its use in the preparation of a medicament for the treatment of migraine

Info

Publication number
IL147154A
IL147154A IL14715400A IL14715400A IL147154A IL 147154 A IL147154 A IL 147154A IL 14715400 A IL14715400 A IL 14715400A IL 14715400 A IL14715400 A IL 14715400A IL 147154 A IL147154 A IL 147154A
Authority
IL
Israel
Prior art keywords
migraine
medicament
preparation
treatment
eletriptan hemisulphate
Prior art date
Application number
IL14715400A
Other languages
English (en)
Other versions
IL147154A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL147154A0 publication Critical patent/IL147154A0/xx
Publication of IL147154A publication Critical patent/IL147154A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14715400A 1999-09-28 2000-09-14 Polymorphic salt of eletriptan hemisulphate and its use in the preparation of a medicament for the treatment of migraine IL147154A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9922963.5A GB9922963D0 (en) 1999-09-28 1999-09-28 Polymorphic salt
PCT/IB2000/001305 WO2001023377A2 (en) 1999-09-28 2000-09-14 Polymorphic salt

Publications (2)

Publication Number Publication Date
IL147154A0 IL147154A0 (en) 2002-08-14
IL147154A true IL147154A (en) 2005-11-20

Family

ID=10861767

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14715400A IL147154A (en) 1999-09-28 2000-09-14 Polymorphic salt of eletriptan hemisulphate and its use in the preparation of a medicament for the treatment of migraine

Country Status (50)

Country Link
US (1) US6369094B1 (zh)
EP (1) EP1233960B1 (zh)
JP (1) JP3795395B2 (zh)
KR (1) KR100479897B1 (zh)
CN (1) CN1155594C (zh)
AP (1) AP2004A (zh)
AR (1) AR025779A1 (zh)
AT (1) ATE246185T1 (zh)
AU (1) AU779580B2 (zh)
BG (1) BG65161B1 (zh)
BR (1) BR0014272A (zh)
CA (1) CA2379572C (zh)
CO (1) CO5180567A1 (zh)
CR (1) CR6561A (zh)
CU (1) CU23200A3 (zh)
CZ (1) CZ2002971A3 (zh)
DE (1) DE60004262T2 (zh)
DK (1) DK1233960T3 (zh)
DZ (1) DZ3254A1 (zh)
EA (1) EA004510B1 (zh)
EE (1) EE200200171A (zh)
EG (1) EG24143A (zh)
ES (1) ES2200911T3 (zh)
GB (1) GB9922963D0 (zh)
GE (1) GEP20043365B (zh)
GT (1) GT200000159A (zh)
HK (1) HK1048628B (zh)
HR (1) HRP20020270B1 (zh)
HU (1) HUP0202821A3 (zh)
IL (1) IL147154A (zh)
IS (1) IS2162B (zh)
MA (1) MA26821A1 (zh)
MX (1) MXPA02003311A (zh)
MY (1) MY121170A (zh)
NO (1) NO321936B1 (zh)
NZ (1) NZ516093A (zh)
OA (1) OA12024A (zh)
PA (1) PA8498901A1 (zh)
PE (1) PE20010662A1 (zh)
PL (1) PL354960A1 (zh)
PT (1) PT1233960E (zh)
SI (1) SI1233960T1 (zh)
SK (1) SK3982002A3 (zh)
TN (1) TNSN00187A1 (zh)
TR (1) TR200200804T2 (zh)
TW (1) TWI265926B (zh)
UA (1) UA72272C2 (zh)
WO (1) WO2001023377A2 (zh)
YU (1) YU2602A (zh)
ZA (1) ZA200202406B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060025387A1 (en) * 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US7132549B2 (en) 2003-05-30 2006-11-07 Pfizer Inc. Process
GB0312478D0 (en) * 2003-05-30 2003-07-09 Pfizer Ltd Improved process
AU2005311714B2 (en) * 2004-12-03 2010-09-30 Merck Sharp & Dohme Corp. Pharmaceutical composition containing an anti-nucleating agent
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
KR100814109B1 (ko) * 2006-01-09 2008-03-14 한국생명공학연구원 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물
TWI394753B (zh) * 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉（ｔｅｔｏｍｉｌａｓｔ）晶體
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
RS62600B1 (sr) 2009-10-26 2021-12-31 Merck Sharp & Dohme Čvrste farmaceutske kompozicije koje sadrže inhibitor integraze

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559129A (en) 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5607951A (en) 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
AU651637B2 (en) * 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
US5559246A (en) 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds
WO1999001135A1 (en) 1997-07-03 1999-01-14 Pfizer Limited Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

Also Published As

Publication number Publication date
TWI265926B (en) 2006-11-11
MA26821A1 (fr) 2004-12-20
BG65161B1 (bg) 2007-04-30
KR100479897B1 (ko) 2005-03-31
PT1233960E (pt) 2003-11-28
ZA200202406B (en) 2003-05-28
PL354960A1 (en) 2004-03-22
GEP20043365B (en) 2004-05-10
CA2379572C (en) 2006-11-14
MY121170A (en) 2005-12-30
DK1233960T3 (da) 2003-10-27
NO20021525D0 (no) 2002-03-26
CN1155594C (zh) 2004-06-30
NZ516093A (en) 2005-01-28
JP2003510318A (ja) 2003-03-18
HUP0202821A2 (hu) 2003-01-28
DE60004262D1 (de) 2003-09-04
TNSN00187A1 (fr) 2005-11-10
HRP20020270B1 (en) 2004-04-30
NO321936B1 (no) 2006-07-24
ATE246185T1 (de) 2003-08-15
CZ2002971A3 (cs) 2003-04-16
NO20021525L (no) 2002-03-26
EA004510B1 (ru) 2004-04-29
PE20010662A1 (es) 2001-06-23
HRP20020270A2 (en) 2003-06-30
EE200200171A (et) 2003-06-16
WO2001023377A2 (en) 2001-04-05
EG24143A (en) 2008-08-06
DZ3254A1 (fr) 2001-04-05
CN1364166A (zh) 2002-08-14
CO5180567A1 (es) 2002-07-30
HK1048628B (zh) 2004-10-21
WO2001023377A3 (en) 2002-03-07
HUP0202821A3 (en) 2003-12-29
UA72272C2 (uk) 2005-02-15
BR0014272A (pt) 2002-05-21
AU779580B2 (en) 2005-01-27
OA12024A (en) 2006-04-19
GT200000159A (es) 2002-03-20
AU6721300A (en) 2001-04-30
CA2379572A1 (en) 2001-04-05
CU23200A3 (es) 2007-04-06
WO2001023377A9 (en) 2002-03-28
YU2602A (sh) 2004-11-25
EA200200302A1 (ru) 2002-10-31
JP3795395B2 (ja) 2006-07-12
KR20020032627A (ko) 2002-05-03
IS2162B (is) 2006-11-15
BG106240A (en) 2002-07-31
TR200200804T2 (tr) 2002-07-22
HK1048628A1 (en) 2003-04-11
CR6561A (es) 2005-04-04
ES2200911T3 (es) 2004-03-16
DE60004262T2 (de) 2004-01-22
GB9922963D0 (en) 1999-12-01
IS6223A (is) 2002-01-08
EP1233960B1 (en) 2003-07-30
SK3982002A3 (en) 2003-05-02
MXPA02003311A (es) 2002-10-04
SI1233960T1 (en) 2003-12-31
AR025779A1 (es) 2002-12-11
PA8498901A1 (es) 2004-02-07
US6369094B1 (en) 2002-04-09
AP2004A (en) 2009-06-10
EP1233960A2 (en) 2002-08-28
AP2002002457A0 (en) 2002-06-30
IL147154A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
ZA200108413B (en) Use of glycosyceramide synthesis inhibitors in therapy.
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HUP0200441A3 (en) Tetrahydropyran derivatives and their use as therapeutic agents and process for preparation the compounds
IL145150A0 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL147154A (en) Polymorphic salt of eletriptan hemisulphate and its use in the preparation of a medicament for the treatment of migraine
HUP0202048A3 (en) Use of alpha1betha1 integrin receptor inhibitors and tgf-betha1 inhibitors in the treatment of kidney disease
IL136960A0 (en) Combination therapy for the treatment of migraine
SI1176976T2 (sl) Uporaba LH, dajanega v srednji ali pozni folikularni fazi, za zdravljenje anovulatornih žensk
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL130171A0 (en) Therapeutic use of melatonin
AU3843600A (en) Bath equipped with water vibrator and therapeutic method using the same
HUP0001891A2 (en) Medicament for the treatment of migraine
IL136962A0 (en) Combination therapy for the treatment of migraine
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
IL136024A0 (en) Combination therapy for the treatment of migraine
GB9906130D0 (en) Compounds for use in therapy
IL149653A0 (en) 2-arylquinoline derivatives, preparation and therapeutic use thereof
GB9911238D0 (en) Therapeutic use
GB9928852D0 (en) Compound for use in water treatment
GB9928845D0 (en) Compound for use in water treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees